ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 1
Clinical trials for ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 1 explained in plain language.
Never miss a new study
Get alerted when new ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 1 trials appear
Sign up with your email to follow new studies for ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart rhythm battle: zapping vs. pills for Life-Threatening condition
Disease control OngoingThis study compares two approaches for controlling dangerous rapid heart rhythms (ventricular tachycardia) in people with weakened heart muscles. Researchers are testing whether a procedure called catheter ablation (using heat or cold to destroy small areas of heart tissue causin…
Matched conditions: ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 1
Phase: NA • Sponsor: Western Sydney Local Health District • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Experimental drug targets deadly heart rhythm disorder
Disease control TerminatedThis early-stage study is testing whether an experimental drug called IC14 can help control arrhythmogenic cardiomyopathy, a serious heart condition that causes dangerous irregular heartbeats. Five patients who already have implanted defibrillators will receive four intravenous i…
Matched conditions: ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 1
Phase: PHASE1, PHASE2 • Sponsor: Implicit Bioscience • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC